Healthcare Services

Pyrogen Testing Market Forecast Covering Industry Demand And Market Evolution

June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Forecasted Market Size Figures For The Pyrogen Testing Market In 2026 And 2030?

The pyrogen testing market has witnessed substantial expansion in recent years. Forecasts indicate its size will increase from $1.91 billion in 2025 to $2.16 billion in 2026, progressing at a compound annual growth rate (CAGR) of 13.0%. Historically, this market expansion is largely due to the growth in pharmaceutical manufacturing capacity, higher production volumes of injectable drugs and vaccines, mandatory regulatory requirements for pyrogen testing, the widespread adoption of LAL-based assays, and the advancement in biologics development.

The pyrogen testing market is projected for significant expansion in the coming years. By 2030, its value is anticipated to reach $3.42 billion, demonstrating a compound annual growth rate (CAGR) of 12.2%. This growth during the forecast period is largely due to factors such as the wider acceptance of rFC and MAT assays, increased capital expenditure in biopharmaceutical research and development, the scaling up of cell and gene therapy production, a heightened emphasis on animal-free testing methodologies, and greater automation within quality control laboratories. Key developments expected over the forecast period involve a growing preference for recombinant and in vitro pyrogen tests, a notable transition away from animal-derived testing approaches, an increasing need for detection assays that are both rapid and highly sensitive, the proliferation of automated endotoxin testing equipment, and a stronger commitment to regulatory adherence in biopharmaceutical production.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4020&type=smp

What Primary Factors Are Fueling The Expansion Of The Pyrogen Testing Market?

The rising investments in research and development (R&D) by pharmaceutical and biotechnology companies are expected to propel the growth of the pyrogen testing market going forward. This testing involves assessing drugs and biologics to ensure they are free from fever-inducing contaminants, such as endotoxins, a crucial step for safe product manufacturing. The increase in R&D spending is primarily driven by the necessity to develop advanced therapies and biologics that mandate stringent quality control and safety checks. Pyrogen testing encourages greater R&D investments by confirming the safety and regulatory compliance of new drugs and biologics, thereby empowering pharmaceutical and biotechnology firms to confidently develop innovative treatments. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures climbed from $892 billion in 2022 to $940 billion in 2023, marking a $48 billion increase. Therefore, the growing R&D investments by pharmaceutical companies are stimulating the expansion of the pyrogen testing market.

Pyrogen Testing Market Driver: Increasing Prevalence Of Infectious Diseases Boosts Demand For Pyrogen Testing

The growing occurrence of tuberculosis (TB) is anticipated to drive the future growth of the pyrogen testing market. Tuberculosis is an infectious illness caused by the bacterium Mycobacterium tuberculosis, primarily affecting the lungs but capable of spreading to other organs, and remains a leading preventable cause of death globally. The increase in TB cases is fueled by factors such as population growth, urbanization, and inadequate access to healthcare, leading to higher infection rates among vulnerable populations. Pyrogen testing supports pharmaceutical safety by guaranteeing that drugs and medical devices are free from fever-inducing contaminants, such as bacterial endotoxins, thereby protecting patients. For example, in May 2025, according to the World Health Organization (WHO), a Switzerland-based health standards organization, approximately 10.8 million people developed TB worldwide in 2023, leading to 1.25 million deaths. These statistics highlight the escalating burden of a highly infectious disease and underscore the critical need for rigorous safety testing in pharmaceutical manufacturing. Consequently, the rising incidence of TB is boosting the growth of the pyrogen testing market.

How Is The Pyrogen Testing Market Structured Across Different Market Segments?

The pyrogen testing market covered in this report is segmented –

1) By Test Type: LAL Test, In Vitro Test, Rabbit Test

2) By Product And Service: Assays, Kits, And Reagents, Instruments, Services

3) By Application: Pharmaceutical And Biologics, Medical Devices, Other Applications

Subsegments:

1) By Test Limulus Amebocyte Lysate (LAL) Test: Gel Clot LAL Test, Chromogenic LAL Test, Turbidimetric LAL Test

2) By In Vitro Test: Monocyte Activation Test (MAT), Recombinant Factor C (rFC) Assay, Other In Vitro Tests

3) By Rabbit Test: Pyrogen Test in Rabbits, Other Animal-Based Tests

What Trends Are Influencing The Pyrogen Testing Market Outlook?

Who Are The Leading Firms Participating In The Pyrogen Testing Market?

Major companies operating in the pyrogen testing market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories Inc., Lonza Group Ltd., Ellab A S, Nelson Laboratories LLC, Associates of Cape Cod Inc., GenScript Biotech Corporation, bioMerieux SA, Hyglos GmbH, Wako Chemicals USA Inc., Pyrostar International Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Group, Sigma Aldrich Co. LLC, Bio Rad Laboratories Inc., Microcoat Biotechnologie GmbH, Sartorius AG, Pacific Biolabs Inc., Toxikon Corporation, STERIS Corporation, Avance Biosciences Inc., BioReliance Corporation, Microbiological Consulting LLC, Microbac Laboratories Inc., North American Science Associates Inc., Pace Analytical Life Sciences LLC

Access The Complete Pyrogen Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pyrogen-testing-global-market-report

Which Region Stands As The Largest Contributor To The Pyrogen Testing Market?

North America was the largest region in the pyrogen testing market in 2025. Asia-Pacific is expected to continue to be the fastest growing region in the pyrogen testing market share during the forecast period. The regions covered in the pyrogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pyrogen Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=4020&type=smp

Browse Through More Reports Similar to the Global Pyrogen Testing Market 2026, By The Business Research Company

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Automotive Shielding Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-shielding-global-market-report

Metal Structural Insulation Panels Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795